Why Clover, DroneShield, Imugene, and New Hope Shares Are Racing Higher Today
ASX Midday Sector Update: Healthcare, Energy Stocks Soar, Utilities Struggle
Imugene Obtains US FDA Fast Track Designation for Azer-cel Lymphoma Treatment; Shares Up 6%
Guess Which ASX Stock Is Surging 11% on Big US FDA News
Imugene Limited Reports Progress in Cancer Therapies
Why Are ASX 200 Tech Stocks Getting Slammed on Tuesday?
Imugene Ltd: Half Yearly Report and Accounts
Why GQG, Imugene, Mirvac, and Temple & Webster Shares Are Pushing Higher
Imugene Therapy Achieves Two Complete Responses in Patients With Blood Cancer, Shares Rise Past 8%
Which ASX 200 Healthcare Share Will Pay the Best Dividend Yield in 2025?
Imugene Receives A$11.7 Million R&D Tax Refund
Imugene Receives A$11.7 Million R&D Tax Refund | ASX:IMU, OTC:IUGNF
Imugene Ltd: Imugene Receives $11.7m R&D Tax Refund
Why Cettire, Gold Road, Imugene, and Paladin Energy Shares Are Racing Higher
First Aussie Doses Bring Imugene Major Step Closer to 'Quicker, Cheaper' Non-Hodgkin's Lymphoma Care
Guess Which ASX Small Cap Stock Is Jumping on 'Significant Milestone'
Imugene Says First Australian Patient Dosed in Lymphoma Trial
ASX Preview: Australian Shares to Open Lower Amid Wall Street Losses
Imugene Receives Substantial Capital Injection; Extends Cash Runway to End of 2025 in Support of Ongoing Trials
Imugene to Raise AU$46 Million in Convertible Notes, Warrants Issue